Naproxen

Naproxen

SCHEMBL2345440

CC(=O)O.COc1ccc2cc([C@H](C)C(=O)O)ccc2c1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGS1PTGS2

The experimentally established mechanism targets of Naproxen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS2 known ✓ P35354 3/20 0.94
PTGS1 known ✓ P23219 3/20 0.94
AKR1C3 P42330 12/20 0.94
AKR1C2 P52895 12/20 0.94
TSHR P16473 2/20 0.94
CDC42 P60953 1/20 0.94
RAC1 P63000 1/20 0.94
CYP1A2 P05177 1/20 0.94
SLC22A6 Q4U2R8 1/20 0.94
LMNA P02545 1/20 0.68
MAPT P10636 1/20 0.68
CYP2C9 P11712 1/20 0.68
TDP1 Q9NUW8 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
AKR1C1 Q04828 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naproxen SCHEMBL29350675 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL30346195 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL3046 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL42434 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL616149 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL29350704 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL28834409 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL10029028 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL215236 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR
Naproxen SCHEMBL29360045 0.97 AKR1C3 (1.00) AKR1C3AKR1C2PTGS2PTGS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190024-A9 COMPOSITION COMPRISING BORNYL ACETATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF STRESS-RELATED DISORDER 경희대학교 산학협력단 2021-01-07 WO claimed
WO-2020190024-A2 COMPOSITION COMPRISING BORNYL ACETATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF STRESS-RELATED DISORDER 경희대학교 산학협력단 2020-09-24 WO claimed
EP-3834635-B1 FUNCTIONAL CIGARETTE FILTER CONTAINING NATURAL PLANT MATERIAL, CIGARETTE, AND METHOD FOR PRODUCING SAME KT & G CORP (KR) 2024-03-20 EP disclosed
US-20230071441-A1 CIGARETTE FILTER CONTAINING NATURAL PLANT MATERIAL, PREPARATION METHOD THEREOF, AND CIGARETTE INCLUDING THE FILTER KT & G CORPORATION (KP) 2023-03-09 US disclosed
EP-3834635-A1 FUNCTIONAL CIGARETTE FILTER CONTAINING NATURAL PLANT MATERIAL, CIGARETTE, AND METHOD FOR PRODUCING SAME KT & G Corporation (KR) 2021-06-16 EP disclosed
WO-2021080193-A1 FUNCTIONAL CIGARETTE FILTER CONTAINING NATURAL PLANT MATERIAL, CIGARETTE, AND METHOD FOR PRODUCING SAME 주식회사 케이티앤지 2021-04-29 WO disclosed
WO-2020190024-A9 COMPOSITION COMPRISING BORNYL ACETATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF STRESS-RELATED DISORDER 경희대학교 산학협력단 2021-01-07 WO disclosed
WO-2020190024-A2 COMPOSITION COMPRISING BORNYL ACETATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF STRESS-RELATED DISORDER 경희대학교 산학협력단 2020-09-24 WO disclosed
US-20190053545-A1 METHODS AND SYSTEMS FOR SUBSTANCE REDUCTION VIA ELECTRONIC VAPOR DEVICE DELIVERY LUNATECH, LLC 2019-02-21 US disclosed
US-8007842-B2 Composition for inhalation therapy and methods of use TOWER LABORATORIES, LTD. (US) 2011-08-30 US disclosed
US-20070184000-A1 COMPOSITION FOR INHALATION THERAPY AND METHODS OF USE PHYZZ. INC. (US) 2007-08-09 US disclosed
EP-0313302-B1 PHOTOPROTECTION COMPOSITIONS COMPRISING SORBOHYDROXAMIC ACID THE PROCTER & GAMBLE COMPANY (US) 1991-12-18 EP disclosed
EP-0313302-A2 Photoprotection compositions comprising sorbohydroxamic acid THE PROCTER & GAMBLE COMPANY (US) 1989-04-26 EP disclosed